ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1818

Epigenetic Profiling of Childhood-onset Lupus Reveals Distinct Epigenetic Clusters and Suggests Epigenetic Drivers of Disease Activity

Desire Casares Marfil1, Gülşah Kavrul Kayaalp2, Vafa Guliyeva2, Özlem Akgün2, Şeyma Türkmen3, Elif Kilic Konte4, Seher Şener5, Sezgin Sahin4, Ozgur Kasapcopur6, Betul Sozeri7, Selçuk Sözer Tokdemir8, Seza Özen9, Nuray Aktay Ayaz2 and Amr Sawalha1, 1University of Pittsburgh, Pittsburgh, PA, 2Istanbul University Faculty of Medicine, Istanbul, Turkey, 3University of Health Sciences, Umraniye Research and Training Hospital, Istanbul, Turkey, 4Istanbul University Cerrahpasa Medical School, Istanbul, Turkey, 5Hacettepe University Faculty of Medicine, Ankara, Turkey, 6Istanbul University-Cerrahpasa, Cerrahpasa Medical School, istanbul, Turkey, 7Health sciences university, Istanbul, Turkey, 8Istanbul University, Istanbul, Turkey, 9Hacettepe University Medical Faculty, Ankara, Turkey

Meeting: ACR Convergence 2025

Keywords: Epigenetics, Pediatric rheumatology, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 28, 2025

Title: (1809–1829) Pediatric Rheumatology – Basic Science Poster

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Childhood-onset lupus is generally associated with a more severe disease course than adult-onset lupus. DNA methylation alterations are known to play a key role in lupus pathogenesis. While we previously showed that childhood-onset lupus is linked to a higher genetic risk burden compared to adult-onset disease, the epigenetic landscape of childhood-onset lupus remains largely unexplored. This study aimed to characterize DNA methylation changes in childhood-onset lupus.

Methods: A total of 64 patients with childhood-onset lupus and 47 healthy controls were included in this study, along with an independent validation cohort of 38 additional patients. DNA was isolated from PBMCs in the study cohort and from whole blood in the validation cohort to assess DNA methylation using the Infinium MethylationEPIC v2.0 array (Illumina). Quality controls and statistical analyses were performed using minfi and limma R packages. Methylation differences among groups were tested through linear regression, adjusting for age, sex, medication use, and cell subset compositions. Differences in clinical manifestations were assessed using Fisher’s exact tests. Gene ontology enrichment analyses were performed with Metascape and GREAT.

Results: Case-control differential DNA methylation analysis revealed significant hypomethylation in interferon-regulated genes in lupus, such as DTX3L, PARP9, IFI44L, and MX1. The enrichment analysis confirmed the presence of type I interferon signature-related biological processes, consistent with adult-onset lupus. Hypomethylation in genes related to B cell activation and cellular senescence was correlated with more active disease, as measured by SLEDAI scores. K-means clustering analysis of patients based on DNA methylation patterns identified 3 distinct lupus clusters. Cluster 1 was characterized by the enrichment of hypomethylated genes involved in cell adhesion and response to growth factor pathways; Cluster 2 exhibited hypomethylation in genes related to regulation of cell differentiation and cell fate determination; and Cluster 3 was enriched in response to oxidative stress and Rap1 signaling pathway in hypomethylated genes. Sex-based analysis revealed hypomethylation in males at sites enriched in immune response pathways, with over 80% of differentially methylated positions in male individuals with childhood-onset lupus validated in the replication cohort.

Conclusion: Childhood-onset lupus is marked by significant hypomethylation in interferon-regulated genes, with DNA methylation changes correlating with disease activity and revealing distinct epigenetic molecular subgroups. Sex-specific patterns further suggest epigenetic contributions to sex-based disease heterogeneity in lupus.

Supporting image 1K-means clustering of patients with childhood-onset lupus based on DNA methylation profiles. Hypomethylated CpG sites characteristic of each cluster were analyzed for functional enrichment, revealing significant overrepresentation in Gene Ontology (GO) biological processes and KEGG pathways.


Disclosures: D. Casares Marfil: None; G. Kavrul Kayaalp: None; V. Guliyeva: None; Ö. Akgün: None; Ş. Türkmen: None; E. Kilic Konte: None; S. Şener: None; S. Sahin: None; O. Kasapcopur: None; B. Sozeri: None; S. Sözer Tokdemir: None; S. Özen: Novartis, 6, Pfizer, 6, Sobi, 6; N. Aktay Ayaz: None; A. Sawalha: None.

To cite this abstract in AMA style:

Casares Marfil D, Kavrul Kayaalp G, Guliyeva V, Akgün Ö, Türkmen Ş, Kilic Konte E, Şener S, Sahin S, Kasapcopur O, Sozeri B, Sözer Tokdemir S, Özen S, Aktay Ayaz N, Sawalha A. Epigenetic Profiling of Childhood-onset Lupus Reveals Distinct Epigenetic Clusters and Suggests Epigenetic Drivers of Disease Activity [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/epigenetic-profiling-of-childhood-onset-lupus-reveals-distinct-epigenetic-clusters-and-suggests-epigenetic-drivers-of-disease-activity/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/epigenetic-profiling-of-childhood-onset-lupus-reveals-distinct-epigenetic-clusters-and-suggests-epigenetic-drivers-of-disease-activity/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology